Latest News and Press Releases

BRIDGEWATER, N.J., Nov. 29, 2018 (GLOBE NEWSWIRE) -- Clinical Genomics, a leading provider of cancer diagnostic solutions including liquid biopsy tests, today announced its partnership with the...

Relationship ensures broad access to innovative FIT test in the U.S. BRIDGEWATER, N.J., and SECAUCUS, N.J., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Clinical Genomics, a leading innovator of tests for...

BRIDGEWATER, N.J., Oct. 26, 2018 (GLOBE NEWSWIRE) -- Clinical Genomics, a leading provider of cancer diagnostic solutions including liquid biopsy tests, today announced the appointment of Betsy...

BRIDGEWATER, N.J., Oct. 16, 2018 (GLOBE NEWSWIRE) -- Clinical Genomics, a leading provider of cancer testing solutions and liquid biopsy testing, today announced two appointments to the company’s...

Overcoming the stigma associated with colorectal cancer screening; former NFL players lead the way by undertaking colonoscopy and InSure ONE FIT testing in Super Bowel I BRIDGEWATER, N.J., Aug. 24,...

BRIDGEWATER, N.J., June 14, 2018 (GLOBE NEWSWIRE) -- Clinical Genomics, a leading provider of colorectal cancer testing and solutions, is pleased to announce that its CLIA licensed and CAP...

Clinical Genomics drives the commercialization of Colvera™, a liquid biopsy test service for colorectal cancer (CRC) recurrence and the focus of growing clinical evidence to support its use as the...

BRIDGEWATER, N.J., May 24, 2018 (GLOBE NEWSWIRE) -- Clinical Genomics, a leading provider of colorectal cancer (CRC) testing and solutions, today announced that data demonstrating the utility of...

BRIDGEWATER, N.J., March 06, 2018 (GLOBE NEWSWIRE) -- Clinical Genomics, a leading provider of colorectal cancer testing and solutions, is pleased to announce that its CLIA licensed and CAP...

BRIDGEWATER, N.J., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Clinical Genomics, manufacturer of fecal immunochemical tests for colorectal cancer screening programs, announces that in a study of more than...